Erythropoietin attenuated vascular dysfunction and inflammation by inhibiting NADPH oxidase-derived superoxide production in nitric oxide synthase-inhibited hypertensive rat aorta

European Journal of Pharmacology

Volumn 691, Issue 1-3, 2012, Pages 190-197

  Toba, Hiroe ^a   Kojima, Yushi ^a   Wang, Jiahong ^a   Noda, Kazuk ^a   Tian, Wei ^a   Kobara, Miyuki ^a   Nakata, Tetsuo ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Antioxidant; Aorta; Erythropoietin; Nitric oxide; Superoxide

Indexed keywords

ACETYLCHOLINE; COPPER ZINC SUPEROXIDE DISMUTASE; DRINKING WATER; HEME OXYGENASE 1; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; OSTEOPONTIN; PROTEIN KINASE B; RECOMBINANT ERYTHROPOIETIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; SUPPRESSOR OF CYTOKINE SIGNALING 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA DISEASE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HEMATOCRIT; HEMATOPOIESIS; HYPERPLASIA; HYPERTENSION; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; MACROPHAGE MIGRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TREATMENT DURATION; TREATMENT RESPONSE; VASCULAR DISEASE; VASCULAR RING; VASCULITIS; VASODILATATION;

ACETYLCHOLINE; ADVENTITIA; ANIMALS; AORTA; BLOOD PRESSURE; BODY WEIGHT; ERYTHROPOIETIN; GENE EXPRESSION REGULATION; HEMATOCRIT; HEME OXYGENASE-1; HUMANS; HYPERTENSION; INFLAMMATION; MACROPHAGES; MALE; NADPH OXIDASE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE; OSTEOPONTIN; PHOSPHOPROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; SUPEROXIDES; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84864987318     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.07.018     Document Type: Article

References (48)

1. D.R. Alessi, and P. Cohen Mechanism of activation and function of protein kinase B Curr. Opin. Genet. Dev. 8 1998 55 62 (Pubitemid 28122141)
2. F.H. Bahlmann, R. Song, S.M. Boehm, M. Mengel, R. von Wasielewski, C. Lindschau, T. Kirsch, K. de Groot, R. Laudeley, E. Niemczyk, F. Guler, J. Menne, H. Haller, and D. Fliser Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure Circulation 110 2004 1006 1012 (Pubitemid 39128626)
3. V. Bellizzi, M. Sabbatini, G. Fuiano, G. Sansone, P. Magri, F. Uccello, M. Andreucci, L. De Nicola, and B. Cianciaruso The impact of early normalization of haematocrit by erythropoietin on renal damage in the remnant kidney model Nephrol. Dial. Transplant. 13 1998 2210 2215 (Pubitemid 28416543)
4. S. Blankenberg, S. Barbaux, and L. Tiret Adhesion molecules and atherosclerosis Atherosclerosis 170 2003 191 203 (Pubitemid 37377790)
5. D. Burger, M. Lei, N. Geoghegan-Morphet, X. Lu, A. Xenocostas, and Q. Feng Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase Cardiovasc. Res. 72 2006 51 59 (Pubitemid 44310637)
6. D. Burger, F. Xiang, L. Hammoud, X. Lu, and Q. Feng Role of heme oxygenase-1 in the cardioprotective effects of erythropoietin during myocardial ischemia and reperfusion Am. J. Physiol. Heart Circ. Physiol. 296 2009 H84 93
7. L.A. Calo, L. Stanic, P.A. Davis, E. Pagnin, G. Munaretto, M. Fusaro, S. Landini, A. Semplicini, and A. Piccoli Effect of epoetin on HO-1 mRNA level and plasma antioxidants in hemodialysis patients. Int. J. Clin. Pharmacol. Ther. 41 2003 187 192 (Pubitemid 36603760)
8. L.C. Cantley The phosphoinositide 3-kinase pathway Science 296 2002 1655 1657 (Pubitemid 34579158)
9. H. Cetin, S. Olgar, F. Oktem, M. Ciris, E. Uz, C. Aslan, and F. Ozguner Novel evidence suggesting an anti-oxidant property for erythropoietin on vancomycin-induced nephrotoxicity in a rat model Clin. Exp. Pharmacol. Physiol. 34 2007 1181 1185 (Pubitemid 47416355)
10. P.K. Chatterjee Pleiotropic renal actions of erythropoietin Lancet 365 2005 1890 1892 (Pubitemid 40744968)
11. Z.Z. Chong, J.Q. Kang, and K. Maiese Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases Circulation 106 2002 2973 2979 (Pubitemid 35424751)
12. L.V. d'Uscio, L.A. Smith, and Z.S. Katusic Erythropoietin increases expression and function of vascular copper- and zinc-containing superoxide dismutase Hypertension 55 2010 998 1004
13. L.V. d'Uscio, L.A. Smith, A.V. Santhanam, D. Richardson, K.A. Nath, and Z.S. Katusic Essential role of endothelial nitric oxide synthase in vascular effects of erythropoietin Hypertension 49 2007 1142 1148 (Pubitemid 351664320)
14. V. De Gennaro Colonna, A. Rigamonti, S. Fioretti, S. Bonomo, B. Manfredi, P. Ferrario, M. Bianchi, F. Berti, E.E. Muller, and G. Rossoni Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats Eur. J. Pharmacol. 516 2005 253 259 (Pubitemid 40922746)
15. J. Downward Mechanisms and consequences of activation of protein kinase B/Akt Curr. Opin. Cell Biol. 10 1998 262 267 (Pubitemid 28174769)
16. W. Durante Targeting heme oxygenase-1 in vascular disease Curr. Drug Targets 11 2010 1504 1516
17. F.M. Faraci, and S.P. Didion Vascular protection: superoxide dismutase isoforms in the vessel wall Arterioscler. Thromb. Vasc. Biol. 24 2004 1367 1373 (Pubitemid 39050427)
18. K. Genc, M.Y. Egrilmez, and S. Genc Erythropoietin induces nuclear translocation of Nrf2 and heme oxygenase-1 expression in SH-SY5Y cells Cell Biochem. Funct. 28 2010 197 201
19. C.M. Giachelli, N. Bae, M. Almeida, D.T. Denhardt, C.E. Alpers, and S.M. Schwartz Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques J. Clin. Invest. 92 1993 1686 1696 (Pubitemid 23304531)
20. S. Hamed, I. Barshack, G. Luboshits, D. Wexler, V. Deutsch, G. Keren, and J. George Erythropoietin improves myocardial performance in doxorubicin-induced cardiomyopathy Eur. Heart J. 27 2006 1876 1883 (Pubitemid 44297396)
21. D.G. Harrison, H. Cai, U. Landmesser, and K.K. Griendling Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease J. Renin Angiotensin Aldosterone Syst. 4 2003 51 61 (Pubitemid 36790175)
22. T. Ikeda, T. Shirasawa, Y. Esaki, S. Yoshiki, and K. Hirokawa Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta J. Clin. Invest. 92 1993 2814 2820 (Pubitemid 24006549)
23. A.G. Jegalian, and H. Wu Differential roles of SOCS family members in EpoR signal transduction J. Interferon Cytokine Res. 22 2002 853 860 (Pubitemid 35217516)
24. W. Jelkmann Molecular biology of erythropoietin Intern. Med. 43 2004 649 659 (Pubitemid 39264162)
25. M. Joyeux-Faure Cellular protection by erythropoietin: new therapeutic implications? J. Pharmacol. Exp. Ther. 323 2007 759 762 (Pubitemid 350146047)
26. P. Katavetin, R. Inagi, T. Miyata, J. Shao, R. Sassa, S. Adler, N. Eto, H. Kato, T. Fujita, and M. Nangaku Erythropoietin induces heme oxygenase-1 expression and attenuates oxidative stress Biochem. Biophys. Res. Commun. 359 2007 928 934 (Pubitemid 46946906)
27. D.L. Krebs, and D.J. Hilton SOCS: physiological suppressors of cytokine signaling J. Cell Sci. 113 2000 2813 2819
28. L. Li, G. Takemura, Y. Li, S. Miyata, M. Esaki, H. Okada, H. Kanamori, N.C. Khai, R. Maruyama, A. Ogino, S. Minatoguchi, T. Fujiwara, and H. Fujiwara Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy Circulation 113 2006 535 543
29. L. Liaw, M. Almeida, C.E. Hart, S.M. Schwartz, and C.M. Giachelli Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro Circ. Res. 74 1994 214 224 (Pubitemid 24029153)
30. A. Manea, L.I. Tanase, M. Raicu, and M. Simionescu Jak/STAT signaling pathway regulates nox1 and nox4-based NADPH oxidase in human aortic smooth muscle cells Arterioscler. Thromb. Vasc. Biol. 30 2009 105 112
31. R.T. Means Jr., and S.B. Krantz Progress in understanding the pathogenesis of the anemia of chronic disease Blood 80 1992 1639 1647
32. A. Mitra, S. Bansal, W. Wang, S. Falk, E. Zolty, and R.W. Schrier Erythropoietin ameliorates renal dysfunction during endotoxaemia Nephrol. Dial. Transplant. 22 2007 2349 2353 (Pubitemid 47244715)
33. T. Miyake, C.K. Kung, and E. Goldwasser Purification of human erythropoietin J. Biol. Chem. 252 1977 5558 5564 (Pubitemid 8167007)
34. S. Moncada, R.M. Palmer, and E.A. Higgs Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacol. Rev. 43 1991 109 142
35. N. Paschos, M.G. Lykissas, and A.E. Beris The role of erythropoietin as an inhibitor of tissue ischemia Int. J. Biol. Sci. 4 2008 161 168 (Pubitemid 351872045)
36. A.I. Rojo, M. Salinas, D. Martin, R. Perona, and A. Cuadrado Regulation of Cu/Zn-superoxide dismutase expression via the phosphatidylinositol 3 kinase/Akt pathway and nuclear factor-kappaB J. Neurosci. 24 2004 7324 7334 (Pubitemid 39100701)
37. R. Ross Atherosclerosis-an inflammatory disease New Engl. J. Med. 340 1999 115 126
38. G. Russo, J.A. Leopold, and J. Loscalzo Vasoactive substances: nitric oxide and endothelial dysfunction in atherosclerosis Vascul. Pharmacol. 38 2002 259 269 (Pubitemid 36398259)
39. A.V. Santhanam, L.A. Smith, K.A. Nath, and Z.S. Katusic In vivo stimulatory effect of erythropoietin on endothelial nitric oxide synthase in cerebral arteries Am. J. Physiol. Heart Circ. Physiol. 291 2006 H781 786
40. D.R. Senger, S.R. Ledbetter, K.P. Claffey, A. Papadopoulos-Sergiou, C.A. Peruzzi, and M. Detmar Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin Am. J. Pathol. 149 1996 293 305 (Pubitemid 26231000)
41. D. Sorescu, D. Weiss, B. Lassegue, R.E. Clempus, K. Szocs, G.P. Sorescu, L. Valppu, M.T. Quinn, J.D. Lambeth, J.D. Vega, W.R. Taylor, and K.K. Griendling Superoxide production and expression of nox family proteins in human atherosclerosis Circulation 105 2002 1429 1435 (Pubitemid 34263273)
42. P. Stralin, K. Karlsson, B.O. Johansson, and S.L. Marklund The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase Arterioscler. Thromb. Vasc. Biol. 15 1995 2032 2036
43. J.C. Tan, and R. Rabkin Suppressors of cytokine signaling in health and disease Pediatr. Nephrol. 20 2005 567 575 (Pubitemid 41166608)
44. H. Toba, M. Morishita, C. Tojo, A. Nakano, Y. Oshima, Y. Kojima, M. Yoshida, K. Nakashima, J. Wang, M. Kobara, and T. Nakata Recombinant human erythropoietin ameliorated endothelial dysfunction and macrophage infiltration by increasing nitric oxide in hypertensive 5/6 nephrectomized rat aorta Eur. J. Pharmacol. 656 2011 81 87
45. H. Toba, K. Nakashima, Y. Oshima, Y. Kojima, C. Tojo, A. Nakano, J. Wang, M. Kobara, and T. Nakata Erythropoietin prevents vascular inflammation and oxidative stress in subtotal nephrectomized rat aorta beyond haematopoiesis Clin. Exp. Pharmacol. Physiol. 37 2010 1139 1146
46. B.D. Westenbrink, E. Lipsic, P. van der Meer, P. van der Harst, H. Oeseburg, G.J. Du Marchie Sarvaas, J. Koster, A.A. Voors, D.J. van Veldhuisen, W.H. van Gilst, and R.G. Schoemaker Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization Eur. Heart J. 28 2007 2018 2027 (Pubitemid 47579534)
47. B.D. Westenbrink, W.P. Ruifrok, A.A. Voors, R.G. Tilton, D.J. van Veldhuisen, R.G. Schoemaker, W.H. van Gilst, and R.A. de Boer Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure Cardiovasc. Res. 87 2010 30 39
48. N. Yazihan, O. Karakurt, and H. Ataoglu Erythropoietin reduces lipopolysaccharide-induced cell damage and midkine secretion in U937 human histiocytic lymphoma cells Adv. Ther. 25 2008 502 514